EVQLV
Richard Fox is the Chief Scientific Officer at EVQLV. Previously, Richard was a Director of Preclinical Development at Pure Biologics. Richard holds a Ph.D. in Cardiovascular Pathology from University of Washington.
This person is not in any offices